Intuitive Surgical director Barratt sells 1,150 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Intuitive Surgical Inc. (ISRG) director Craig H. Barratt exercised 1,150 non-qualified stock options on November 4, 2026, acquiring 1,150 common shares at an exercise price of $90.4944 per share, then sold 1,150 shares at a weighted average price of $460.0026 per share under a Rule 10b5-1 trading plan expiring March 15, 2027. The option position following the transaction was 2,335 options, expiring April 20, 2027. A separate indirect holding lists 27,948 common shares by Trust.
Insider Trade Summary 10b5-1
Exercise and Sale: 1,150 shares ($425K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
BARRATT CRAIG H
Role
Director
Sold
1,150 shs ($529K)
Approx. gross sale proceeds
$529K
Approx. exercise cost
$104K
Approx. pre-tax spread
$425K
Share of Position Sold
100%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) F1, F3 | 1,150 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 1,150 | $90.4944 | $104K |
| Sale | Common Stock F1, F2 | 1,150 | $460.0026 | $529K |
| Holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 2,335 contracts (Direct);
Common Stock — 0 shares (Direct);
Common Stock — 27,948 shares (Indirect, by Trust)
Holdings Before and After:
Non-Qualified Stock Option (right to buy), 3,485 to 2,335 contracts (Direct);
Common Stock, 0 to 0 shares (Direct)
Other Insiders: 4 other insiders reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (3)
- F1. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on March 15, 2027.
- F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $460.00 to $460.005 as follows: 541 shares sold at $460.00; and 609 shares sold at $460.005. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F3. Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.
Key Figures
Options exercised: 1,150 options
Exercise price: $90.4944 per share
Common shares sold: 1,150 shares
+4 more
7 metrics
Options exercised
1,150 options
November 4, 2026
Exercise price
$90.4944 per share
Options exercised November 4, 2026
Common shares sold
1,150 shares
November 4, 2026
Weighted average sale price
$460.0026 per share
November 4, 2026
Sale price range
$460.00 to $460.005 per share
Prices reported for the November 4, 2026 sale
Options following transaction
2,335 options
Expiration date: April 20, 2027
Indirect common-share holding
27,948 shares
Held by Trust
Key Terms
Non-Qualified Stock Option, Rule 10b5-1, weighted average sale price, vesting
4 terms
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Rule 10b5-1 regulatory
"Trading Plan that complies with SEC Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
weighted average sale price financial
"The price reported in Column 4 is a weighted average sale price"
vesting financial
"Option shall vest 100% one year after the date of grant"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were the vesting terms for Craig H. Barratt's ISRG stock option?
The non-statutory option granted under the Non-Employee Directors' Stock Option Plan was to vest 100% one year after the grant date or at the next shareholders meeting, whichever occurred first. Vesting was to cease upon termination of his service as a director.
AI-generated analysis. How Rhea-AI works. Not financial advice.
